Skip to main content
SpringerLink
Log in

Association between in utero valproate exposure and spina bifida

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Haug U, et al. Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida Pharmacoepidemiology and Drug Safety : 19 Nov 2022. Available from: URL: http://doi.org/10.1002/pds.5573

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Association between in utero valproate exposure and spina bifida. Reactions Weekly 1935, 8 (2022). https://doi.org/10.1007/s40278-022-28803-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28803-8

Search

Navigation